SK Chairman Plans 'Much Bigger' US Investment

SK Group Chairman Chey Tae-won announced that the South Korean conglomerate has a "much, much bigger" plan for increased investment in the United States. Speaking in an interview with Bloomberg, Chey did not specify the exact amount or timeline for these future investments but emphasized their substantial scale.

This announcement follows SK Group's existing significant commitments to the US market. In 2022, the company pledged to invest $22 billion in the US over the next five years, with a focus on semiconductors, batteries, and biotechnology. A substantial portion of this prior investment was allocated to expanding semiconductor manufacturing capabilities, particularly through its subsidiary SK Hynix.

The conglomerate's US operations already span various sectors. SK On, its electric vehicle battery division, has been actively expanding its production facilities in states like Kentucky and Tennessee, often in partnership with major automakers. SK Bioscience, a vaccine and biopharmaceutical company, has also been exploring opportunities for research and development collaboration and manufacturing presence in the US.

Chey's remarks suggest a strategic deepening of SK Group's presence and financial commitment in the American economy. The conglomerate has been a key player in global supply chains, and further US investment could bolster its position in critical technology sectors and contribute to job creation within the United States. The specific areas of this "much bigger" investment remain to be detailed, but the chairman's statement signals a strong intent to grow the company's footprint.